Showing results (421-430 of 1,155) with videos related to

Sort By:
Pageof 116
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2009
Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group studyBradley J Monk, Michael W Sill, Robert A Burger, et al.
Cancer Reports (Hoboken, N.J.)|May 19, 2021
Impact of short-term Dutasteride treatment on prostate-specific membrane antigen expression in a mouse xenograft modelBenedikt Kranzbühler, Rosa Sousa, Lukas Prause, et al.
Gynecologic Oncology|July 26, 2018
Phase II evaluation of dalantercept in the treatment of persistent or recurrent epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group studyRobert A Burger, Wei Deng, Vicky Makker, et al.
The European Journal of Surgery = Acta Chirurgica|September 1, 1995
Effects of peritonitis exudates on chemotaxis and phagocytosis of human neutrophilsJ A Burger, U Schöffel, M Sach, et al.
Orthopaedic Journal of Sports Medicine|April 23, 2021
Defining Minimal Clinically Important Difference After Open Hip Abductor RepairTyler J Uppstrom, Spencer W Sullivan, Joost A Burger, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Effects of zidovudine on Friend virus complex infection in Rfv-3r/s genotype-containing mice used as a model for HIV infectionJ D Morrey, R P Warren, K M Okleberry, et al.
Immunopharmacology|March 10, 2000
Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected miceR A Burger, J L Billingsley, J H Huffman, et al.
Frontiers in Genetics|July 18, 2019
Natural Killer Cell Receptor Genes in Camels: Another Mammalian ModelJan Futas, Jan Oppelt, April Jelinek, et al.
Annals of Internal Medicine|February 2, 2026
Optimizing Cervical Cancer Screening by Age at Vaccination for Human Papillomavirus: Health and Resource ImplicationsKine Pedersen, Jacopo Di Silvestre, Stephen Sy, et al.
Leukemia & Lymphoma|July 30, 2019
A multicenter phase 1 study of plerixafor and rituximab in patients with chronic lymphocytic leukemiaLeslie A Andritsos, John C Byrd, Peter Cheverton, et al.
Pageof 116